Early results from a phase 2 clinical trial show that denifanstat for 12 weeks improved lesion counts in patients with acne vulgaris.
If you’re someone who’s experienced recurring bouts of cystic acne, you’ll know there’s no one-size-fits-all approach to keeping acne flares at bay. Clearing your skin can feel like a bit of a waiting ...
NBC Select independently determines what we cover and recommend. When you click on or buy through our links, we may earn a commission. Learn more. Accutane can be an effective solution for combating ...
The treatment of acne ( Table I) [1,2,3,4,5,6] is based upon its severity (mild, moderate, severe) and the type(s) of lesion(s) present (noninflammatory, inflammatory, mixed). In general, the ...
When acne debuts as acne fulminans — acne that manifests as an explosive worsening and ulceration of skin lesions and can be associated with systemic symptoms — heritability is a likely culprit. Dawn ...
Denifanstat met all endpoints in a Phase 3 acne trial and showed favorable tolerability. Sagimet also launched a Phase 1 trial for TVB-3567. Sagimet Biosciences announced that its oral fatty acid ...
With a crowded market of skincare products claiming to address acne, skepticism is natural. Norse Organics, known for its natural and sustainable approach, has gained attention for its Acne & Redness ...
TORONTO--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today announced that AviClear, the first and only energy device approved in the United ...
Stem cells help improve acne scars by stimulating collagen and reducing inflammation. Bone marrow and fat-derived stem cells have shown promising results in small studies. Exosomes, the signaling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback